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FACTORS INFLUENCING THE RECEIPT OF DIABETIC RETINOPATHY
SCREENING IN A HIGH-RISK POPULATION.
Elizabeth Fairless, Amber King, Kristen H. Nwanyanwu. Department of Ophthalmology
& Visual Science, Yale School of Medicine, New Haven, CT.
Diabetic retinopathy (DR) is among the leading causes of vision loss in the US,
yet an estimated 50% of patients with diabetes do not receive recommended annual
screening eye exams for reasons that are incompletely understood. Patients with diabetes
and low socioeconomic status or who are racial/ethnic minorities are at increased risk for
vision loss. Qualitative interviews were conducted with 30 patients with diabetes at a
federally qualified community health center and a primary care clinic in New Haven, CT
regarding factors influencing their use of screening exams. The interviews were recorded,
transcribed, and analyzed line by line to identify themes. The themes were organized in a
theoretical framework of factors influencing receipt of screening. Participants identified
as black (16), white (5), Hispanic (5), Asian (1), and other/no answer (3). Twenty-eight
had health insurance. Twenty-four had received an eye exam within in the past year, but
one-third of participants reported they did not receive eye exam yearly. 415 comments
were coded at 22 nodes under 7 broader themes and two overarching categories of
individual factors and institutional/structural factors. Themes included vision status,
competing concerns, emotional context, resource availability, in-clinic experience, cues
to action, and knowledge about diabetes. Among the patients who had not received an
eye exam within the past year, the cost of an exam, lack of insurance coverage, and lack
of prompting by a health provider were among the reported reasons for not pursuing eye
screenings. Many patients lack knowledge about diabetic retinopathy and the utility of
preventative eye care. New strategies for engaging high-risk populations are necessary.
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Introduction

I.

The Diabetes Epidemic
The number of people with diabetes mellitus in the United States and worldwide

is rapidly expanding, leading some scholars to call diabetes the largest epidemic in
human history [1]. Past predictions have underestimated the number of people worldwide
who would develop diabetes. In 2000, the World Health Organization (WHO) predicted
there would be 366 million people worldwide with diabetes by 2030, but by 2015 there
were already 415 million people with the disease [1]. In the United States in 2015, there
were an estimated 30 million people with diabetes, equaling 9.4% of the population [2].
The WHO estimates that 1.6 million deaths in 2016 worldwide were directly attributable
to diabetes [3].

Diabetes mellitus is a chronic metabolic disease characterized by elevated blood
glucose that over time causes macrovascular and microvascular damage throughout the
body. Diabetes can lead to serious morbidity including cardiovascular disease, stroke,
kidney disease, and limb amputations. Type 2 diabetes, characterized by insulin
resistance, is the most common type. Type 1 diabetes, also known as juvenile diabetes, is
characterized by impaired insulin production. The risk factors for type 2 diabetes are
heterogenous. Obesity, inactivity, and poor diet have demonstrable links to an increased
risk of diabetes, and correspondingly, lifestyle interventions aimed at addressing these
factors have been shown to reduce the incidence of diabetes [3,4]. However, other non-
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modifiable factors such as genetic susceptibility and epigenetic changes are increasingly
being recognized [1,4,5].

There are disparities in who is affected by diabetes. According to the Centers for
Disease Control, in the United States in 2015 the prevalence of diabetes was 12.7% for
non-Hispanic blacks, 12.1% for Hispanics, 8% for Asians, and 7.4% for whites [2].
American Indians/Alaska Natives had over double the prevalence (15.1%) compared to
whites. Indigenous people are disproportionally affected by diabetes, with some
Aboriginal Australian communities and Native American communities having the highest
rates of diabetes in the world [1]. Black, Hispanic, and Native American people are also
more likely than their white counterparts to suffer complications from diabetes, such as
diabetic retinopathy [6].

II. Diabetic Retinopathy
Diabetic retinopathy (DR) is a microvascular and neurodegenerative complication
of diabetes. Chronic hyperglycemia triggers a cascade of biochemical changes within the
retina that include increased inflammation, oxidative stress, and advanced glycation endproducts that result in vascular damage and neuroretinal compromise [7]. The initial
disease stages are a spectrum of non-proliferative retinopathy characterized by vascular
endothelial injury within the blood vessels of the retina. This vascular damage leads to
microhemorrhages, microaneurysms, retinal infracts, or leakage of lipids and plasma
proteins into the retina [5]. If this leakage occurs in the macula, it can cause macular
edema and vision loss. Over time, retinal non-perfusion can trigger growth of abnormal
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retinal blood vessels, a state termed proliferative diabetic retinopathy. This
neovascularization can extend into the vitreous, putting traction on the retina and leading
to detachment. In addition, the fragile, abnormal vessels easily hemorrhage. Both of these
complications can lead to severe vision loss [5,8]. The presence of DR heralds systemic
vascular complications: it is associated with double to triple the risk of stroke, coronary
artery disease, and heart failure [9–11].

One meta-analysis estimates that there are 93 million people worldwide with DR,
including 28 million with vision-threatening DR [12]. In the United States, diabetic
retinopathy is among the leading causes of vision impairment and blindness [5]. The
prevalence of DR in patients with diabetes is approximately 30% [13]. DR can occur in
both type 1 and type 2 diabetes. Nearly all patients with type 1 diabetes eventually
develop retinopathy and 50-60% of patients with type 2 diabetes develop some degree of
retinopathy during their lifetime [8,13]. Up to 21% of patients with type 2 diabetes
already have retinopathy at the time of their first diagnosis with diabetes [8]. One in ten
people with diabetes will develop a vision-threatening form of DR [14].

There are a number of risk factors for DR that are well-documented, including
poor glycemic control, poor blood pressure control, and a longer duration of diabetes
[12]. However, these factors only account for some of the risk of developing DR, and
much of the remaining risk is not well understood [15]. Socioeconomic factors may have
a profound effect the health of patients with diabetes and their ability to influence the
aforementioned risk factors [16]. Socioeconomic status can potentially affect many facets
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of a patient’s experience, from access to medical care, community resources, and social
support, to knowledge about diabetes, communication with providers, and ability to
adhere to treatment plans [16]. The environment in which a patient lives may influence
their risk for diabetes and its complications. For example, whether a patient lives in a
neighborhood that is safe, walkable, and with access to healthy foods [17].

Paralleling the racial disparities in the prevalence of diabetes, racial and ethnic
minorities are also at increased risk of developing DR and vision-threatening forms of
DR [2,18–20]. In one study that examined the third National Health and Nutrition
Examination Survey (NHANES III) data, non-Hispanic Blacks were found to have a
prevalence of DR 46% higher than non-Hispanic Whites, and Mexican-Americans were
found to have a prevalence of DR 84% higher [20]. For Native Americans, there are few
studies of DR rates. Prevalence of DR in this population has been documented as
between 38-59% in reports from the 1980s and 1990s, whereas a newer study places the
prevalence of DR at 20% [21].

III. Prevention and Treatment of Diabetic Retinopathy and the Role of Screening
Blindness from diabetic retinopathy is largely preventable, yet one in ten people
with diabetes will develop vision-threatening DR [14,22]. Diabetic retinopathy, like
many eye diseases, has no early symptoms or warning signs [5]. Many patients with DR
are unaware they have the condition: one study of NHANES data from 2005-2008
found that of patients with DR evident on fundus photographs, only 26.1% answered
yes to “Have you been told by a doctor that diabetes has affected your eyes or that you
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had retinopathy?” [23]. Of patients with diabetic macular edema, only 44.7% answered
yes [23].

Intensive glycemic and blood pressure control can significantly reduce the risk
of developing DR and slow its progression [24,25]. A 1% reduction in glycated
hemoglobin (HbA1c) can reduce the risk of retinopathy by approximately 40% [5,7,24].
Tight blood pressure control (< 150/85 mm Hg) can reduce the risk of DR progression
by approximately one-third [25]. Treatments to reduce vision loss in proliferative DR
include panretinal laser photocoagulation or intravitreal anti-vascular endothelial
growth factor (VEGF) therapy, each aimed at reducing the pro-angiogenic signaling that
leads to neovascularization in the retina [5]. Anti-VEGF therapies can also be used to
treat diabetic macular edema, as can intraocular steroids in some cases [5]. In patients
with a tractional retinal detachment or persistent vitreous hemorrhage, surgical removal
of the vitreous (vitrectomy) may be necessary [7]. These treatments for DR are highly
effective and can reduce severe vision loss by 50- 94% [26,27].

Early detection of DR through routine eye examinations and early treatment is
key to prevent major vision loss [5,28]. The rationale for screening for DR is clear: DR
is highly prevalent within a distinct group of people (patients with diabetes), early
disease is asymptomatic and can be easily detected with screening methods, and there
are effective treatments that can reduce disease burden [5]. Screening is also a costeffective intervention, saving approximately $100 million federal dollars annually
[26,29].
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Screening guidelines recommend that patients with type 2 diabetes be screened
for DR with a comprehensive dilated eye examination at the time of their diagnosis and
annually thereafter. Adult patients with type 1 diabetes should be screened annually after
they’ve had the disease for greater than five years [8,30]. Although screening with a
clinical examination by an ophthalmologist would be ideal, there are logistical and
resource limitations to screening every patient with diabetes in this manner. The
invention of non-mydriatic digital retinal photography offers a new solution large-scale
DR screening. Retinal photographs can be taken in a primary care setting and transmitted
to reading centers where they can be evaluated for DR, and appropriate referrals to an
ophthalmologist can then be made [5].

IV. Utilization of Screening for Diabetic Retinopathy
Despite the importance of annual screening for DR in order to receive early
treatment and prevent vision loss, it is estimated that non-adherence to screening is
high. Various studies estimate that between 35-50% of patients with diabetes do not
receive necessary screening [22,26,31,32]. There are a number of factors that have been
shown to be associated with receipt of appropriate screening, or eye care utilization
more generally. These include, but are not limited to, socioeconomic status, insurance
status, access to care, and race/ethnicity.

Socioeconomic status. Zhang et al. found that patients with any age-related eye
disease (age-related macular degeneration, cataract, diabetic retinopathy, or glaucoma)
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were less likely to have had an eye examination in the last year if they had a lower
income or less than a high school education [33]. Chou et al. found similar disparities
along income and educational lines using data from the 2006-2009 Behavioral Risk
Factor Surveillance System [34].

Insurance status. A study by Lee et al. used data from the National Health
Interview Survey to examine eye care utilization. For people without insurance, eye
care utilization rates of 14%, 24%, and 36% were found for people with no, some, or
severe visual impairment respectively. For those with insurance, utilization rates were
found to be significantly higher at 34%, 54%, and 60% for the same degrees of visual
impairment, respectively [35]. A study by Shi et al. using data from the Medical
Expenditure Panel Survey Household Component (2002–2009) including the Diabetes
Care Survey found that insurance was the most significant factor for receiving an eye
examination, but noted racial/ethnic disparities even among insured patients [36]

Access to care. People living in rural areas have been shown to have lower rates
of eye care utilization [37]. Native Americans have well documented barriers to access
and utilization of healthcare, even if they reside in urban areas [38].

Race/ethnicity. Racial/ethnic minority status has consistently been shown to be
associated with decreased utilization of eye examinations and decreased access to eye
care [26,36,39–41]. Lee et al found lower rates of eye care utilization among certain
Hispanic subgroups: Mexican Americans and Cuban Americans [35]. In the SEE
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Project, a population-based survey of persons aged 65-84 in Maryland, only half of
black participants reported seeing an eye doctor in the past year, compared to 69% for
white participants [42]. In one study at a large Indian Health Service clinic, adherence
to DR screening was 50%, although this was able to be increased to 75% with
implementation of a digital retinal imaging system in the primary care setting [43].

V. Purpose of Current Study
A review of the literature has demonstrated that the patient populations with
greater disease burden from diabetic retinopathy, in particular racial/ethnic minorities and
those with low socioeconomic status, are also the same patient populations less likely to
get necessary screening examinations. In other words, the patients that need screening the
most are less likely to receive it. As detailed above, there are a complex network of
biologic, socioeconomic, and environmental factors that influence the risk of developing
diabetes and diabetes-related complications, and influence screening utilization.
Understanding and intervening upon these factors is key to improving outcomes for
patients with diabetes.

Despite a wealth of data indicating disparities in DR screening utilization, there
remains relatively few studies that examine patient perspectives on screening, especially
from patient populations at high risk for vision loss, namely racial/ethnic minorities and
those with low socioeconomic status. Previous studies have used focus groups to
investigate the receipt of eye care more generally and have shown that patients’ perceived
barriers to eye care include cost, insurance status, transportation, lack of communication
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with the physician, lack of trust, burden of systemic disease, absence of symptoms, and
no perceived need for examination [20,28,44,45]. Elam and Lee conducted focus groups
with high risk patients in North Carolina and found that a lack of trust in their provider or
in the healthcare system was the most common barrier cited among under-utilizers of eye
care [44]. Alexander et al. conducted focus groups with randomly selected participants
from each racial group and reported participants generally lacked knowledge about eye
health and that few were counseled by their primary care providers about eye care [28].
Fisher et al. conducted focus groups about adherence to dilated eye exams with both
patients with diabetes and with physicians in internal medicine and ophthalmology. The
authors report that a lack of awareness of insurance benefits was the most common
barrier identified by patients, whereas a lack of education about the importance of eye
exams was the most common barrier reported by physicians [45].

Research that solicits the experiences of patients with diabetes at higher risk for
vision loss, namely racial and ethnic minorities and patients with low socioeconomic
status, is necessary to understand how this unique population engages with diabetic eye
care. Understanding the factors that influence receipt of eye care by high-risk patients
with diabetes is essential for the design of effective interventions that increase screening
utilization and decrease the burden of DR. In this study, we present the findings from
individual qualitative interviews with high-risk diabetic patients from a federally
qualified community health center about their use of DR screening, and propose a
theoretical framework to characterize the factors that influence receipt of diabetic eye
care in this population.
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Methods
I.

Qualitative Methods and Their Utility
Qualitative research is research that attempts to answer why or how a

phenomena occurs using non-numerical data. It typically uses inductive rather than
deductive reasoning and seeks to generate rather than test hypotheses [46]. Qualitative
methods may be useful in describing a range of phenomena, as Curry et al describes:
“Although quantitative methods have historically been the primary approach in
health sciences research, many contemporary phenomena in health and health
care are difficult, if not impossible, to measure using quantitative approaches
alone. Examples include complex and dynamic social processes; beliefs, values,
and motivations that underlie individual health behaviors; and social, political,
economic, and organizational contexts relevant to health…The goal is to produce
depth of understanding, and perhaps generate hypotheses regarding a
phenomenon, its precursors, and its consequences [46].”
Qualitative methods offer a way to explore the diverse experiences of patients,
particularly from at-risk communities [14–16][46]. In qualitative research, data is
typically collected through observational or descriptive methods, such as one-on-one
interviews or focus groups, using purposeful sampling of individuals with direct
experience or knowledge of the topic under study. Data is analyzed in an iterative
manner in which data is collected, coded, and interpreted. The products of analysis in
qualitative data often include recurrent themes, hypotheses, or conceptual models [46].

In this study we sought to understand the factors influencing DR screening
utilization by patients from racial/ethnic minority groups and low socioeconomic status.
The complexity of this phenomena makes qualitative methods an ideal method to gain
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understanding about the personal choices and factors that influence individual patient’s
decision-making.

In this study, the data was gathered and analyzed in accordance with the
principles of grounded theory, a systematic methodology in which theories are
developed through inductive reasoning [47]. As qualitative data is reviewed, repeated
concepts are tagged with “codes,” and refined as more data is collected and codes are
re-reviewed. Then, codes can be grouped within concepts and larger categories that may
become the basis for a new theory. This allows the researcher to “develop a theoretical
account of the general features of a topic while simultaneously grounding the account in
empirical observations or data [48].”

II. Setting
The institutional review board of Yale University approved the study protocol
and exempted it from continued oversight. Discussion with leaders of local community
health organizations through the Yale Center for Research and Engagement informed
the study design. The mission of the center is to “facilitate the collaboration of
community organizations with trainees to design and implement research projects on
topics identified as priorities by the New Haven community [49].”

Semi-structured, qualitative interviews were conducted with patients with
diabetes at the Cornell Scott Hill Health Clinic, a federally-qualified community health
center (FQHC) in New Haven, CT, and its satellite clinics in New Haven and nearby
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Ansonia, CT. Additional interviews were conducted at the Yale Primary Care Clinic in
New Haven, CT. The FQHC serves a patient population that is 69% Black or Latino
and 64% of patients have income below the poverty line [50]. The Yale Primary Care
Clinic serves a similar patient population. The interview settings included primary care
clinics, a diabetes/wellness education center, and an on-site eye clinic.

III. Participants
A convenience sample of English-speaking patients with diabetes was recruited
by approaching patients before or after their appointments. Author E. Fairless recruited
26 of the 30 participants, and A. King, also a medical student, recruited the remaining 6.
All participants gave written informed consent and consent to be audio-recorded. No
compensation was given to the first 24 participants, the 6 final participants received $20
gift cards for their time. Only patients with a diagnosis of diabetes for at least one year
were included. Self-reported participant demographic information was collected,
including age, gender, race/ethnicity, insurance status, time since diagnosis with
diabetes, time since last eye exam, and frequency of eye exams.

IV. Participant Interviews
Semi-structured qualitative interviews were conducted in English with
participants by in a one-on-one setting. Author E. Fairless conducted 24 out of 30
interviews, and A. King conducted an additional 6 interviews. Based on the principles
of grounded theory, the purpose of these interviews was to generate hypotheses rather
than to test a predetermined hypothesis [46,47,51]. Participants were asked open-ended
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questions about their experiences with eye exams, what factors influenced their decision
to pursue or not to pursue an eye exam, and any barriers they might have faced to
accessing eye care. Author E. Fairless developed the interview guide that was used to
direct questioning (Table 1).

Interview Guide
When was the last time you had an eye exam? How often do you get eye
exams?
Can you tell me about your experience the last time you had an eye exam?
What made you decide to get an eye exam? What motivated you to go?
At the time that you were diagnosed with diabetes, what, if anything, were
you told about eye care?
Have you ever been told by a healthcare provider that diabetes can affect
your eyes?
How
did you learn
that diabetes
affect
youraneyes?
Has anything
ever prevented
youcan
from
having
eye exam? Have you ever
cancelled or not shown up to an eye exam appointment? If so, why?
Table 1. Interview guide.

Follow-up questions were used to encourage participants to elaborate as necessary. The
interview guide was periodically re-evaluated and rephrased by the author using a
reflection checklist as necessary to ensure clarity and internal validity [51].

V. Data Analysis
The interviews were recorded using a H4next Handy Recorder (ZOOM
corporation.), transcribed verbatim with Trint online transcription service (Trint Ltd.),
and analyzed with NVivo software, version 11 (QSR International.) The author E.
Fairless transcribed the 24 interviews she conducted, and A. King transcribed the 6
17

interviews she conducted. The transcripts were analyzed according to the concepts of
grounded theory [47]: the transcripts were reviewed line by line and codes were created
to define concepts inductively from the data. Coded text was reviewed to identify
overarching themes and codes were refined as appropriate until a final comprehensive
coding framework was reached. All interviews were reviewed and coded by author E.
Fairless. Dr. K. Nwanyanwu reviewed the transcripts and coding.

This coding framework became the basis of a theoretical model of factors affecting
screening utilization. Author E. Fairless and Dr. K. Nwanyanwu developed the
theoretical model. The broader themes of the coding framework were organized in a
socio-ecological model, which situates health behaviors in the context of individual
(e.g. attitudes, behaviors), social (e.g. social networks, social support), and structural
(e.g. access to care) factors [52,53].
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Results
I.

Participant Demographics
A total of 30 people participated in the study. The median age of participants was

57.3 (range 35 –73). Fifteen participants identified as female and 15 as male.
Participants identified as black (16), white (5), Hispanic (5), Asian (1), and
other/declined to answer (3). Twenty-eight participants had health insurance. Twentyfour had received an eye exam within in the past year, but one-third (10) of participants
reported they did not receive eye exam yearly. Half of the participants had had diabetes
for over 10 years. The demographic information is summarized in Table 2.

Demographic Information
N = 30
Age, median (range)
57.3 (35-73)
Gender, No. (%)
Female
15 (50)
Male
15 (50)
Race/ethnicity, No. (%)
Black
16 (53)
White
5 (16.6)
Hispanic/Latino
5 (16.6)
Asian
1 (3.3)
Other/declined to answer
3 (10)
Insurance Status, No. (%)
Insured
28 (93)
Uninsured
2 (7)
Most Recent Eye Exam, No. (%)
Within previous 12 Months
24 (80)
Not within previous 12 months
6 (20)
Eye Exam frequency, No. (%)
Annually or more frequently
20 (66)
Less frequently than annually
10 (33)
Duration of diabetes, No. (%)
1 to 5 years
12 (40)
6 to 9 years
3 (10)
10 years or longer
15 (50)
Table 2. Participant demographic information.
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II. Interview Comments
415 interview comments were coded at 22 nodes under 7 broader themes. These
themes were further classified into either individual factors or institutional and
structural factors based on a socio-ecological model. Individual factors included the
themes of vision status, competing concerns, and emotional context. Institutional and
structural factors included the themes of resource availability, in-clinic experience, cues
to action [54,55], and knowledge-creating experiences. This coding framework became
our theoretical model of the factors affecting utilization of eye examinations in our
patient population (Figure 1).
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Figure 1: Theoretical framework of factors affecting utilization of eye exams in patients
with diabetes, and representative quotes from participants.

Individual factors. Individual factors included vision status, competing
concerns, and emotional context. Individual factors encompassed factors that were
either specific to a patient, such as attitude and behaviors, health issues, or were factors
closely relating to their daily lives.

Vision status: Many participants indicated that changes in their vision or a need
for updated corrective lenses was the primary factor that prompted them to seek an eye
examination. In the absence of any visual symptoms, some participants saw no reason
21

to obtain an eye exam. One participant with diabetic retinopathy recalled not seeking an
eye exam until his vision was affected by a retinal hemorrhage: “[The doctors] started
saying ‘You gotta see an eye doctor.’…[I] blew off the first appointment, and then I was
half-blind, so I saw the doctor properly.” Another participant stated ‘It wasn’t until I
myself noticed a difference in my own eyesight that made want to [get an exam.]” Many
participants stated that updating their glasses each year was an independent motivating
factor to get exams regardless of their need for DR screening. One participant with gout
recalled: “I was struggling to get here [to the eye clinic]. I wasn't gonna come. I was
going to call because of my foot, because I can't put pressure on my foot… I made it
here, I struggled. Again, because I want some new glasses.”

Competing concerns: Participants expressed that competing concerns such as
other health problems, childcare responsibilities, struggles with addiction, and
employment scheduling influenced their ability to get regular eye exams. One
participant recalled that her previous job schedule kept her from making health
appointments: “I canceled a few appointments over the last three months because I had
a new job. So now I'm going to work on getting all those appointments rescheduled and
done because I'm not working now.”

Emotional context: Some participants expressed fear or hesitation about
receiving eye exams because they were concerned that they would receive bad news
about their health or because they wanted to avoid painful procedures. One participant
stated: “I didn't think I needed [an eye exam]. And a lot of times when I go to the doctor
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all of the sudden I need stuff. And I didn't want that to happen, I wanted to think that my
eyes were going to be OK.” In contrast, others indicated that a desire to be informed
about their health motivated them to seek exams. Some participants mentioned having a
major health event, such as a hospitalization, that was a “wake up call” that motivated
them to be proactive about accessing healthcare.

Institutional and structural factors. Institutional and structural factors that
influenced receipt of eye care included resource availability, in-clinic experience, cues
to action, and knowledge-creating experiences. Institutional and structural factors were
defined as factors relating to the patient-provider relationship, the healthcare system, or
larger social structures.

Resource availability: Insurance status and the cost of an eye exam were
important factors for participants, particularly among those that had not received an eye
exam in the last year. One participant describes not returning to the eye clinic because
of lack of funds: “I didn't have the money to pay for the amount of money [the eye
clinic] said that I had to pay… I know that [an exam] was important. But I – as a single
parent with three kids – I mean, seeing was not a priority at that time.” Another patient
reported that despite ongoing eye symptoms, he did not get an exam because “it was a
financial thing… I didn’t have the money for it.” Some participants reported being
uninsured as a barrier to receiving eye care One participant reported that “I was doing
like a yearly exam…but I haven’t got one since I haven’t had any insurance maybe 5
years.” She further elaborated that despite prompting by her doctor to get an eye exam,
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she could not find an eye clinic that would see her without insurance coverage. She
reported her income put her a coverage gap where she made too much to qualify for
state Medicaid, but not enough to afford her employer’s health insurance. Several
participants commented that they received eye exams only every two years, as they
believed that annual exams were not covered by their insurance (however, medically
necessary eye exams for patients with diabetes are typically covered annually by most
insurance plans.)

Access to transportation to the eye clinic was another important factor, though
most participants reported that they had no issues with finding adequate transportation.
Additionally, some participants reported that experiencing homelessness or being
incarcerated prevented them from seeking eye exams. One participant described not
having access to eye care while incarcerated: “I was in prison, so they didn’t- they don’t
do all that [eye care]. So when I came home I got everything done.”

In-clinic experience: Participants reported that communication with their
healthcare providers influenced their use of eye care either positively or negatively. One
patient with a positive experience said, “The diabetes has not affected me so far from
what [the doctor] tells me when she sees me in here [at the eye clinic.]...I think the
process works. They are on top of it every year when they go in they are doing the full
work up on me and letting me know that nothing's happening so far.” Another
participant spoke about conflicting information from her providers:
“I'm still having these blurred visions as of today, and- but they're saying that my
eye vision is OK… I don't really know what to think of it because this [doctor]
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saying that and this one is saying that, but I still have the blurry vision from time
to time…what can I do about it? And this one's saying it's OK, this one's saying I
have a trace of cataract but don't worry about it.”
Other participants described instances of clear miscommunication: one participant who
needed surgery on his retina mistakenly believed that the doctors would remove his eye
to perform the surgery. Participants reported that feeling respected by their eye doctor
and having good interactions with clinic staff were also factors that influenced their
experience with eye care.

Cues to action: Participants reported that being prompted by a primary care
provider to receive an eye examination played a large role in their decision to seek an
eye exam. One participant said: “If the doctor would suggest me have an eye exam,
regardless of whether I had diabetes or not I would have followed out the instructions.
If I was on my own I don't think I would have.” This is exemplified by the experience of
another participant who reported being told about the importance of an eye exam and
appropriately referred:
“[My doctors] told me you have to get [an eye exam] done because we want to
see if there's any damage done by you having diabetes and high blood pressures,
so they can both damage your eyesight. And that's why they referred me from
here. They did the appointment and everything, and then all I had was a phone
call and come in.”
In contrast, another participant felt that eye care was not emphasized by his
primary care provider, which delayed his seeking an eye exam:
“I should have been scared into going [to the eye doctor] a little bit, or at least,
you know, given some kind of explanation as to what [diabetic retinopathy] was.
It seemed to be at the bottom of the list. I have a lot of side effects from diabetes
like neuropathy and, you know. But my eyes for some reason seemed to be at the
bottom of the list of the importance layer when I talked to doctors.”
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Participants also reported that following an annual exam schedule and getting
appointment reminders were useful prompts to seek eye exams.

Knowledge-creating experiences: Several participants reported experiences
that informed them about diabetes’ effects on the eye and motivated them to obtain eye
examinations. Some participants learned about diabetic eye disease from their provider,
while others learned from family and friends with diabetes. Some participants reported
knowing people who had become blind from diabetic eye disease. For one man, this
was a powerful motivator to get exams: “One of my sisters lost her eyes [because of
diabetes]…I watched what my sister went through… when I think of her living in
darkness for so long…I don’t want to do that if I don’t have to.”

In contrast, some participants appeared to be unaware or misinformed about
diabetic retinopathy: one participant believed that cataract surgery protected him from
diabetic eye disease: “The diabetes… won't affect me because I've got it - I got lenses in
my eyes. So…it don't really affect my vision like it do some people…They said I could
go get an eye exam, but what am I getting the eye exam for? I already see long
distance….” Some participants stated that they had never been told by their doctor that
diabetes could affect their eyes or that they needed a diabetic eye examination. One
participant states: “I don't think as far as being diagnosed with diabetes…I don't recall
no one telling me [about eye exams], and I'm being completely honest.”
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Discussion
Diabetes is a burdensome disease that places patients, especially racial/ethnic
minorities and people with low socio-economic status, at risk of developing diabetic
retinopathy and vision loss [26,36,39–41]. Many patients at high risk of developing DR
are not receiving the annual screening examinations necessary to identify DR and
intervene before preventable vision loss occurs [18,22,26]. We have proposed a
theoretical framework of factors that influence receipt of DR screening based on
qualitative interviews with high-risk patients with diabetes. These factors are complex
and the results of this qualitative study add depth and detail to our understanding. The
participants in this study spoke about the emotional context behind their disease, their
satisfaction or frustration with their providers’ communication, and their experiences
balancing the demands of their lives with their health issues and available resources.

The results of our interviews indicate a gap in many patients’ understanding of
DR and the utility of preventative eye care. Although DR is asymptomatic in its early
stages, many participants did not seek eye care unless they noticed changes in their vision
or they did not perceive a need for annual eye exams if they felt their vision was good.
Many participants stated that their need for glasses or contacts was a main motivating
factor to pursue a yearly eye exam. It is unclear whether these participants would still be
receiving eye exams to screen for DR if they did not already visit the eye doctor for
corrective lenses. Participants exhibited a range of knowledge about DR, with some
participants understanding that blindness can result from DR and others only expressing
that they knew vision could be affected in some way.
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Our results reinforce the important role primary care providers play in educating
patients about DR and prompting them to stick to annual examination schedules. Many
participants identified their provider’s prompting as a leading reason they sought an eye
exam, even if they did not fully understand the role of an eye exam in their diabetes care
– though education by a provider about DR was demonstrably positive too.
Unfortunately, several participants reported never being told by their primary care
provider about diabetes’ effects on the eye and the need for eye exams, or reported that
they felt eye exams were not emphasized by their provider. Patients with diabetes often
have complex medical needs, other comorbidities, and often other specialists they must
see on an ongoing basis, such as podiatry and dentistry. It is therefore not surprising that
primary care providers often have little time during an appointment to discuss eye care.
The chronic care model is a framework that has been shown to improve the quality of
diabetes care [56]. It includes, among many things, an expanded role for health care
teams and electronic health record tools that can help coordinate delivery of care, both of
which may be useful to primary care providers taking care of the complex needs of
patients with diabetes.

Our results also show that insurance continues to be an important factor
influencing patients’ receipt of eye care, with lack of insurance being a frequently cited
barrier among patients who had not received an eye exam in the past year. In addition,
the overlapping benefits of vision insurance and medical insurance are a source of
confusion for some patients that may negatively impact screening adherence [55].
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Physicians and other healthcare professionals must continue to advocate for policies that
expand insurance coverage.

Many of the factors influencing the receipt of DR screening identified by this
study, such as insurance status, communication with physicians, burden of systemic
disease, absence of visual symptoms, and no perceived need for examination, align with
barriers identified by previous literature about receipt of eye care more generally
[18,28,44]. There are several limitations to our study. Though this study drew participants
from a population that is at higher risk for screening non-adherence, patients who had
indeed received an eye exam within the past year were over-represented in this study.
Nonetheless, these participants provided valuable insights on factors that facilitated DR
screening, and many commented on periods in the past when they were unable to receive
eye care. Patients who have not been screened may be less likely to seek primary care as
well, and were therefore difficult to capture in this study design. Finally, by nature of
being a qualitative study, our data does not allow us to quantitative comparisons about
any of the factors affecting screening that were identified.

New, innovative approaches are necessary to increase awareness about DR,
expand access to screening, and increase screening utilization. Telemedicine provides one
such approach, in which digital retinal photographs are taken and sent to reading centers
for interpretation. Telemedicine can provide high diagnostic accuracy, increase rates of
DR screening, and can be an important tool in settings that serve minority patient
populations [58–61]. In addition, electronic health records are a tool that can generate
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screening reminders and improve communication and coordination between primary care
providers, eye care providers, and patients to facilitate screening [62]. Finally, federally
qualified community health centers (FQHCs) are well-positioned to address the eye care
disparities in high risk patient populations, but further integration of eye care services is
necessary [63,64]. The FQHC in this study had an on-site comprehensive eye clinic,
making it among the only 29% of FQHCs that provide on-site dilated eye examinations
for patients with diabetes [63,65].

Further research is essential to furthering our understanding of underutilization of
care, barriers to care, and factors that facilitate access. The findings reported here may
provide the basis for interventions to increase screening utilization in high-risk
populations. Improving the utilization of DR screening by high risk populations is a
critical imperative given the disproportionate burden of DR and preventable diabetesrelated blindness faced by these populations.
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